Fosravuconazole

Fosravuconazole (Nailin) is an oral triazole antifungal agent approved for the treatment of onychomycosis in Japan since 2017. It has a broad and potent antifungal activity. Fosravuconazole is also effective in treating mycetoma.
Fosravuconazole is a prodrug that is converted into ravuconazole and the mechanism of action is considered to be the inhibition of ergosterol biosynthesis.

Brand names: Nailin (Eisai Ltd, Japan)
Chemical formula: C23H20F2N5O5PS
Systematic chemical name: 4-[2-[(1R,2R)-2-(2,4-Difluorophenyl)-1-methyl-2-[(phosphonooxy)methoxy]-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile

External Link:
Fosravuconazole for onychomycosis (Podiatry Arena)

Other anti fungal drugs:

AntibioticsPolyenes:NystatinAmphotericin BHamycin
Heterocyclic benzofuran:Griseofulvin
Echinocandins:CaspofunginMicafunginAnidulafungin
Azoles:Imidazoles:Topical:ClotrimazoleEconazoleMiconazole
Bifonazole
Systemic:Ketoconazole
Triazoles:FluconazoleItraconazoleVoriconazolePosaconazole
EfinaconazoleFosravuconazole
Morpholines:Amorolfine
Allylamines:Terbinafine (oral)Terbinafine (topical)
Other topical agents:TolnaftateBenzoic acidButenafineSodium thiosulfateQuiniodochlor
Undecylenic acidCiclopirox olamineGentian Violet

Page last updated: @ 6:47 am

 
Comments are closed.